Dr Mustafa Khasraw
NHMRC Clinical Trials Centre, The University of Sydney (NSW)
$359,460
2016 - 2018
The Research
A trial to investigate if the addition of the drug Veliparib to chemotherapy improves outcomes for glioblastoma patients.
share
.svg)
VERTU - Veliparib, Radiotherapy and Temozolomide trial in Unmethylated MGMT Glioblastoma
Glioblastoma
NSW
